ImmunoGen Inc (NASDAQ:IMGN)

8.89
Delayed Data
As of May 22
 +0.07 / +0.79%
Today’s Change
5.34
Today|||52-Week Range
13.78
+45.74%
Year-to-Date
No recent news for ImmunoGen Inc.

Today’s Trading

Previous close8.82
Today’s open8.79
Day’s range8.77 - 8.90
Volume637,761
Average volume (3 months)1,495,991
Market cap$760.2M
Dividend yield--
Data as of 3:59pm ET, 05/22/2015

Growth & Valuation

Earnings growth (last year)+4.60%
Earnings growth (this year)+19.27%
Earnings growth (next 5 years)+15.00%
Revenue growth (last year)+68.55%
P/E ratioNM
Price/Sales8.71
Price/Book10.01

Competitors

 Today’s
change
Today’s
% change
BPMCBlueprint Medicines ...+0.77+2.64%
BCRXBioCryst Pharmaceuti...+0.12+1.06%
OVASOvaScience Inc-0.06-0.19%
OSIROsiris Therapeutics ...-0.16-0.87%
Data as of 4:14pm ET, 05/22/2015

Financials

Next reporting dateJuly 31, 2015
EPS forecast (this quarter)-$0.32
Annual revenue (last year)$59.9M
Annual profit (last year)-$71.4M
Net profit margin-119.15%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Daniel M. Junius
Chief Financial Officer &
Executive Vice President
David B. Johnston
Corporate headquarters
Waltham, Massachusetts

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers